Target intelligence / Profile preview

Venezuelan equine encephalitis virus envelope glycoprotein E1 (E1)

Target
E1
Molecular classification
Envelope glycoprotein, Viral fusion protein
01

Overview

The Venezuelan equine encephalitis virus envelope glycoprotein E1 is a transmembrane glycoprotein that forms heterodimers with E2 on the viral surface, organized into icosahedral spikes on the lipid envelope. E1 mediates low-pH-induced membrane fusion in endosomes by dissociating from E2, exposing its fusion loop, and forming homotrimers that drive viral-endosomal membrane merger for nucleocapsid release. It features a surface-exposed N-linked glycan at Asn134, a buried E2-associated glycan site, and interacts with entry receptors like LDLRAD3 via E1-E2 clefts. E1 contributes to assembly by linking the envelope to the nucleocapsid via transmembrane helices and cytoplasmic tails, with structures resolved by cryo-EM at 4.4 Å for strains like TC-83.

Other names
Spike glycoprotein E1E1 glycoprotein
02

Mechanism of action

Neutralizing antibodies bind E1 fusion loop or E1-E2 interfaces to block attachment and fusion

03

Biological functions

Viral entry and receptor binding (forms heterodimers with E2 for attachment to host receptors like LDLRAD3)Membrane fusion (pH-triggered dissociation from E2 and formation of E1 homotrimers in endosomes)Viral assembly and budding (interacts with capsid and transmembrane regions)
04

Disease associations

Infection (causes Venezuelan equine encephalitis, a severe neurological disease)
05

Safety considerations

Virulence attenuation mutations (e.g., E2 T120R) affect E1-E2 interactions, relevant for live-attenuated vaccines like TC-83

Beyond the preview

Go deeper on Venezuelan equine encephalitis virus envelope glycoprotein E1 (E1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venezuelan equine encephalitis virus envelope glycoprotein E1 (E1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call